irinotecan has been researched along with Sarcoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcamone, G; Bisogno, G; Carli, M; Miglionico, L; Riccardi, R; Scagnellato, A | 1 |
| Brandsma, D; De Jong, FA; Hamberg, P; Sleijfer, S; Verweij, J | 1 |
1 review(s) available for irinotecan and Sarcoma, Small Cell
| Article | Year |
|---|---|
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.
Topics: Adult; Antiemetics; Antineoplastic Agents, Phytogenic; Ataxia; Camptothecin; Capecitabine; Central Nervous System; Colorectal Neoplasms; Cytotoxins; Deoxycytidine; Dexamethasone; Dysarthria; Female; Fluorouracil; Granisetron; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Sarcoma, Small Cell; Serotonin Antagonists; Topoisomerase I Inhibitors | 2008 |
1 other study(ies) available for irinotecan and Sarcoma, Small Cell
| Article | Year |
|---|---|
No effect of irinotecan in patients with resistant desmoplastic small round cell tumor.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Camptothecin; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Fibroma, Desmoplastic; Humans; Irinotecan; Male; Prognosis; Sarcoma, Small Cell | 2010 |